SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Bajasurfer who wrote (596)6/9/1998 1:10:00 AM
From: Jim Mac  Respond to of 1754
 
I can't remember exactly where I read that, but I think it was in a press release from LCAV/LVCI/LZRCF earlier this year.



To: Bajasurfer who wrote (596)6/13/1998 6:14:00 PM
From: majormember  Read Replies (1) | Respond to of 1754
 
All:

SNRS at $7.50, will do for hyperopics what
VISX did for myopics. This is NOT competing with VISX.

Get in on ground floor:

SNRS "LTK" procedure shown on ABC news in New York:
abcnews.com

Also post on Yahoo:
Message 4844701

GREAT DD, follow links:
Message 4148838

Regards,
Skane


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News